Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles-Reference-Cited by-同舟云学术

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

Published:2022-03-17 Issue:4 Volume:76 Page:1121-1134
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Martínez‐Arranz Ibon¹^ORCID,Bruzzone Chiara²,Noureddin Mazen³^ORCID,Gil‐Redondo Ruben²^ORCID,Mincholé Itziar¹,Bizkarguenaga Maider²^ORCID,Arretxe Enara¹^ORCID,Iruarrizaga‐Lejarreta Marta¹^ORCID,Fernández‐Ramos David²^ORCID,Lopitz‐Otsoa Fernando²^ORCID,Mayo Rebeca¹,Embade Nieves²^ORCID,Newberry Elizabeth⁴,Mittendorf Bettina⁵,Izquierdo‐Sánchez Laura⁶,Smid Vaclav⁷,Arnold Jorge⁸^ORCID,Iruzubieta Paula⁹,Pérez Castaño Ylenia¹⁰,Krawczyk Marcin¹¹¹²,Marigorta Urko M.²,Morrison Martine C.¹³,Kleemann Robert¹³,Martín‐Duce Antonio¹⁴,Hayardeny Liat¹⁵,Vitek Libor⁷^ORCID,Bruha Radan⁷^ORCID,Aller de la Fuente Rocío¹⁶,Crespo Javier⁹^ORCID,Romero‐Gomez Manuel¹⁷^ORCID,Banales Jesus M⁶¹⁸,Arrese Marco⁸¹⁹,Cusi Kenneth²⁰,Bugianesi Elisabetta²¹,Klein Samuel⁵,Lu Shelly C.³^ORCID,Anstee Quentin M.²²²³^ORCID,Millet Oscar²^ORCID,Davidson Nicholas O.⁴,Alonso Cristina¹^ORCID,Mato José M.²^ORCID

Affiliation:

1. OWL Metabolomics Derio Bizkaia Spain

2. CIC bioGUNE BRTA CIBERehd Derio Bizkaia Spain

3. Karsh Division of Gastroenterology and Hepatology Cedars‐Sinai Medical Center Los Angeles California USA

4. Department of Medicine Washington University School of Medicine St. Louis Missouri USA

5. Center for Human Nutrition Washington University School of Medicine St. Louis Missouri USA

6. Department of Liver and Gastrointestinal Diseases Biodonostia Research Institute Donostia University Hospital Donostia Spain

7. First Faculty of Medicine Charles University Prague Czech Republic

8. Departamento de Gastroenterologia Escuela de Medicina Pontificia Universidad Católica de Chile Santiago de Chile Chile

9. Marqués de Valdecilla University Hospital Cantabria University Santander Spain

10. Department of Digestive System Osakidetza Basque Health Service Donostia University Hospital San Sebastian Spain

11. Department of Medicine II Saarland University Medical Center Homburg Germany

12. Laboratory of Metabolic Liver Diseases Center for Preclinical Research Department of General, Transplant and Liver Surgery Medical University of Warsaw Warsaw Poland

13. Department of Metabolic Health Research Netherlands Organization for Applied Scientific Research Leiden The Netherlands

14. Alcalá University School of Medicine and Health Sciences University Hospital Prıncipe de Asturias Madrid Spain

15. Galmed Pharmaceuticals Tel Aviv Israel

16. Department of Digestive Disease Clinic University Hospital University Hospital of Valladolid Valladolid Spain

17. Valme University Hospital CiBERehd Sevilla Spain

18. University of the Basque Country CIBERehd IKERBASQUE Donostia Spain

19. Centro de Envejecimiento y Regeneración Santiago Chile

20. Division of Endocrinology, Diabetes and Metabolism University of Florida and Malcom Randall VAMC Gainesville Florida USA

21. Gastroenterology Department University of Turin Turin Italy

22. Translational & Clinical Research Institute Faculty of Medical Sciences Newcastle University Newcastle Upon Tyne UK

23. Newcastle NIHR Biomedical Research Center Newcastle Upon Tyne Hospitals NHS Trust Newcastle Upon Tyne UK

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Horizon 2020 Framework Programme

Comisión Nacional de Investigación Científica y Tecnológica

Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza

Fondo Nacional de Desarrollo Científico y Tecnológico

National Institutes of Health

“la Caixa” Foundation

Agentura Pro Zdravotnický Výzkum České Republiky

Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32427

Reference52 articles.

1. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease

2. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

3. Mechanisms of NAFLD development and therapeutic strategies

4. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

5. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models;Computer Methods and Programs in Biomedicine;2024-10

2. Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease;Physiological Research;2024-08-31

3. Dysfunctional VLDL metabolism in MASLD;npj Metabolic Health and Disease;2024-07-22

4. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26

5. Noninvasive liver fibrosis markers are independently associated with carotid atherosclerosis risk in patients with nonalcoholic fatty liver disease;Scandinavian Journal of Gastroenterology;2024-06-22